Company intelligence / Profile preview

Quibim

Valencia, Valencia, Spainquibim.com ↗

Ownership: Private
Development stage: Commercial

Overview

Quibim has developed over two dozen AI algorithms for quantitative analysis of medical images. Their solutions are used by more than seventy hospitals worldwide and support at least eleven clinical trials. The company’s products have received regulatory clearances such as FDA approval for their prostate cancer detection tool. They have demonstrated value in improving diagnostic accuracy and efficiency across oncology and neurology indications.

Therapeutic areas: OncologyRheumatologyGastroenterologyNeurologyInfectious Diseases
Modalities: Artificial intelligence algorithms for medical imaging (radiomics and deep learning)Not directly therapeutic; focuses on diagnostics and biomarkers from MRI, CT, PET scans
Industry: Medical Imaging

Partnerships

Merck SeronoNovartisJanssenMultiple leading radiologists/hospitals across Europe & US

Beyond the preview

Go deeper on Quibim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quibim.

Explore the full profile